DAC.NYSEDanaos CORP

SCHEDULE 13D/A: Danaos Corporation: Major Shareholder's Stake Rises to 49.4% Following Company Share Repurchases

Sentiment:

Beneficial Ownership Update


An amendment to a Schedule 13D filing reveals that Danaos Investment Limited, as Trustee of the 883 Trust, and Dr. John Coustas now beneficially own 49.4% of Danaos Corporation's common stock, primarily due to the company's ongoing share repurchase program.

Summary

  • Danaos Investment Limited, as Trustee of the 883 Trust ("DIL"), and Dr. John Coustas, collectively the "Reporting Persons," have updated their beneficial ownership in Danaos Corporation.
  • The Reporting Persons now beneficially own 9,338,502 shares of Common Stock, representing 49.4% of the outstanding shares.
  • This increase in percentage ownership is attributed to repurchases made by Danaos Corporation under its common stock repurchase program.
  • DIL, as Trustee of the 883 Trust, holds sole voting and dispositive control over these 9,338,502 shares.
  • Dr. Coustas is deemed to beneficially own these shares due to his power to remove and replace DIL as Trustee of the 883 Trust, though this does not imply economic ownership.
  • Iraklis Prokopakis beneficially owns 200,270 shares (approximately 1.1%) with sole voting and dispositive power.
  • Evangelos Chatzis beneficially owns 73,000 shares (less than 1.0%) with sole voting and dispositive power.
  • No transactions in the Company's Common Stock by the Reporting Persons or Shareholder Directors were effected in the past 60 days.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The increase in beneficial ownership percentage is a direct result of the company's share repurchase program, which is generally viewed favorably by investors as it can enhance shareholder value and indicates financial strength.

Positives

  • The increase in beneficial ownership percentage for the major shareholder (Dr. Coustas and the 883 Trust) is a result of the company's common stock repurchase program, which typically reduces the number of outstanding shares and can be viewed positively by investors as it may enhance earnings per share and signal management confidence.
  • Share repurchases can indicate a company's strong financial position and commitment to returning value to shareholders.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction beyond the ongoing common stock repurchase program.

Industry Context

This filing is a specific disclosure of beneficial ownership changes for Danaos Corporation, a major container ship owner. While it doesn't detail broader industry trends, the company's ability to conduct share repurchases suggests a healthy financial position within the shipping sector, which has seen fluctuating demand and freight rates.

Related Party Transactions

  • The 883 Trust, whose trustee is Danaos Investment Limited (DIL), has beneficiaries including Dr. John Coustas and members of his immediate family. Dr. Coustas has powers to remove and replace DIL as Trustee, linking his beneficial ownership to the trust's holdings.

Stakeholder Impact

  • Shareholders: The company's share repurchase program, which led to the increased percentage ownership for the Reporting Persons, generally benefits existing shareholders by reducing the number of outstanding shares, potentially increasing earnings per share and share price.

Key Dates

DateDescription
2010-08-16Original Schedule 13D filing date
2018-08-14Amendment No. 1 filing date
2019-12-02Amendment No. 2 filing date
2021-09-14Amendment No. 3 filing date
2022-04-15Amendment No. 4 filing date
2023-11-15Amendment No. 5 filing date
2024-11-13Amendment No. 6 filing date
2025-01-14Date of event which requires filing of this statement (triggering event for Amendment No. 7)
2025-01-16Filing date of Amendment No. 7 and Joint Filing Agreement

Keywords

Danaos Corporation, Schedule 13D, Beneficial Ownership, Share Repurchase Program, Common Stock, John Coustas, 883 Trust, SEC Filing, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.